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Abstract
Objective: Paraquat is a highly toxic herbicide that binds strongly to 
tissue and causes high mortality rates due to pesticide intoxication in 
Taiwan. In this study, we evaluated the usefulness of methylprednisolone 
pulse therapy and calculation of the severity index of paraquat poisoning 
(SIPP) to predict the prognosis in patients with oral paraquat intoxication.
Materials and Methods: Thirty-two patients with paraquat poisoning 
from January 2003 to April 2005 were enrolled into this study at a medi-
cal center in eastern Taiwan. All 32 patients had history of oral intake of 
paraquat and urine paraquat was positive at the emergency department. 
Time of oral intake of paraquat and serum paraquat levels were assayed 
at the emergency department for calculating SIPP (hour ˜  mg/L) level. 
Sixteen patients with oral paraquat poisoning were treated with intrave-
nous methylprednisolone 1 g/day and charcoal hemoperfusion for 3 days 
(MP group), and 16 patients with oral paraquat poisoning were treated 
with charcoal hemoperfusion only for 3 days (control group).
Results: The mortality rate of the patients with oral paraquat poisoning 
was high (87.5%). There were no statistically significant differences in 
death (p = 1.000), age (p = 0.706), sex (p = 0.069), serum blood urea nitro-
gen (p = 0.104), creatinine (p = 0.174), aspartate aminotransferase (p = 0.083), 
alanine aminotransferase (p = 0.365), plasma level of paraquat (p = 0.880) 
and SIPP level (p = 0.734) between the MP group and control group. Young 
age (p = 0.030), lower initial plasma paraquat level (p = 0.002), lower 
serum creatinine (p = 0.009), female sex (p = 0.033), lower elapsed time 
from ingestion of paraquat to arrival at hospital (p = 0.035) and SIPP level 
less than 10 (p < 0.001) were associated with survival in patients with oral 
paraquat poisoning. Multivariate forward stepwise linear regression analy-
sis of deaths showed that SIPP > 10 (hour ˜  mg/L) (p < 0.001) was an inde-
pendent predictor of death in patients with oral paraquat poisoning and 
explained 77.1% of the variance (R2 = 0.771).
Conclusion: Treatment with methylprednisolone pulse therapy did not 
show better results in patients with acute oral paraquat poisoning. SIPP was 
an independent predictor of death in patients with oral paraquat poisoning. 
[Tzu Chi Med J 2009;21(2):156–160] 
Article info
Article history:
Received: June 20, 2008
Revised: August 25, 2008






Severity index of paraquat 
 poisoning
 TZU CHI MED J  June 2009  Vol 21  No 2 157
1. Introduction
Paraquat is a contact herbicide that is used world-
wide due to its rapid inactivation in the environment 
[1]. Intentional and accidental ingestion of commercial 
liquid formulations of paraquat has caused a large 
number of human fatalities in Taiwan [2]. Ingestion of 
a large amount of paraquat is considered to be fatal, 
resulting in death due to multiple organ failure and 
cardiogenic shock within 1–4 days [3]. There are three 
degrees of severity in paraquat poisoning [1]. Mild 
poisoning can cause oral irritation and gastric upset, 
and the prognosis is complete recovery. Moderate to 
severe poisoning leads to acute renal failure and, in 
severe cases, hepatitis followed by pulmonary fibro-
sis, and death after 2–3 weeks. Patients with acute 
fulminant paraquat poisoning die from multiple organ 
failure and cardiogenic shock within 7 days. Oxygen 
free radical generation and neutrophil-mediated in-
flammation are responsible for toxicity in humans by 
producing injury to intracellular membranes and or-
ganelles and eventually cell death [4]. Therapy has 
concentrated on reducing paraquat absorption from 
the gastrointestinal tract and increasing its elimina-
tion [3]. However, there is no clinical evidence that 
reducing absorption using Fuller’s earth, activated 
charcoal, or increasing elimination by forced diure-
sis, hemodialysis, hemofiltration, hemoperfusion or 
continuous venovenous hemofiltration has increased 
survival in patients with paraquat poisoning [3,5]. 
Meth ylprednisolone has potent anti-inflammatory and 
immunosuppressive properties [6]. Single high dose 
dexamethasone treatment decreases the pathological 
scores and increases the survival rate after paraquat 
intoxication in rats [7]. Recently, researchers have re-
ported methylprednisolone pulse therapy that can 
prevent the further damage of lung tissue during the 
subacute period of paraquat intoxication in humans 
[8,9]. The aim of this study was to investigate the ef-
ficacy of methylprednisolone pulse therapy in patients 
with acute paraquat poisoning. We used severity 
index of paraquat poisoning (SIPP) to predict the prog-
noses in patients with acute paraquat intoxication.
2. Materials and methods
2.1. Patients
Thirty-two patients with oral paraquat poisoning were 
enrolled in this study from January 2003 to April 
2005 at a medical center in eastern Taiwan. All 32 
patients had positive urine paraquat levels detected 
using sodium dithionite reaction in the emergency 
department (ED). The Protection of Human Subjects 
Institutional Review Board at Tzu Chi University and 
Hospital approved this study. Patients were excluded 
from this study if they had dermal exposure to para-
quat; received intravascular injection of paraquat; did 
not have paraquat levels in their biological fluids; 
arrived in the ED > 24 hours after ingestion of para-
quat; ingested paraquat due to major systemic dis-
eases including cancer, heart, lung, renal, and liver 
diseases; or did not give informed consent.
2.2. Study protocol
Patients were assigned to receive either methylpred-
nisolone (MP) pulse therapy with charcoal hemoper-
fusion (MP group) or only charcoal hemoperfusion 
(control group). Patients in the MP group were treated 
with intravenous MP 1 g on the first day, charcoal 
hemoperfusion every 4 hours on the first day and 
50 g oral activated charcoal every 6 hours for 3 days 
in the intensive care unit. Patients in the control 
group were treated with charcoal hemoperfusion 
every 4 hours on the first day and 50 g oral activated 
charcoal every 6 hours for 3 days in the intensive 
care unit.
2.3. Biochemical investigations
Urine and blood samples were taken on arrival at the 
ED and were used to detect urine paraquat levels 
using sodium dithionite reaction and plasma para-
quat levels with the spectrophotometry method 
(Beckman DU-650, CA, USA). Serum levels of blood 
urea nitrogen (BUN), creatinine (Cr), aspartate ami-
notransferase (AST), and alanine aminotransferase (ALT) 
were measured using an autoanalyzer (Hitachi 747, 
Tokyo, Japan) in the ED. The elapsed time (hours) 
from ingestion of the paraquat to arrival and serum 
paraquat levels was assayed in the ED to calculate 
the SIPP. SIPP (hour ˜  mg/L) means elapsed time 
(hour) ˜  serum paraquat level in the ED (mg/L). We 
used SIPP = 10 (hour ˜  mg/L) to indicate the bound-
ary for survival and death as reported by Yamamoto 
et al [10].
2.4. Statistical analysis
Data are expressed as case number and were ana-
lyzed using the χ2 test. Other data are expressed as 
mean ± standard deviation and compared using the 
nonparametric Mann-Whitney U test. A p value < 0.05 
was considered statistically significant. All statistically 
significant variables (p < 0.05) were put into a multiple 
linear regression model as independent variables and 
mortality was used as a dependent variable. Data 
were analyzed using SPSS version 11.0 (SPSS Inc., 
Chicago, IL, USA) for Windows.
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3. Results
The comparison of clinical and laboratory profiles 
between the MP group and the control group are shown 
in Tables 1 and 2. There were no significant differences 
in gender, survival, age, plasma paraquat level, serum 
BUN, Cr, AST, ALT, survival time, time to arrival or SIPP 
levels between the MP group and control group.
The mortality profiles of paraquat intoxication pa-
tients are shown in Table 3. The mortality rate of pa-
tients with oral paraquat poisoning was high (87.5%). 
Most patients with paraquat poisoning in our study 
were fulminant and died within 7 days after paraquat 
intoxication. Among the 32 patients in our study, 28 
died and four survived. Young age (p = 0.030), lower 
initial plasma paraquat level (p = 0.002), lower serum 
Cr (p = 0.009), female sex (p = 0.033), lower elapsed 
time from ingestion of paraquat to arrival at hospital 
(p = 0.035) and SIPP level less than 10 (p < 0.001) were 
associated with survival. Although being female was 
statistically associated with survival, equal numbers 
of male and female patients died and the difference 
was very small. There were no statistically significant 
differences in survival between the MP group and the 
control group, plasma paraquat level, serum BUN, 
AST, ALT and time to arrival.
Multivariate forward stepwise linear regression 
analysis of the mortality rate showed that SIPP > 10 
was an independent predictor of death in patients with 
paraquat poisoning (R2 = 0.771; p < 0.001) (Table 4).
4. Discussion
Our study showed that treatment with methylpred-
nisolone pulse therapy did not improve the survival 
rate in patients with paraquat poisoning. SIPP was an 
independent predictor of death in patients with oral 
paraquat poisoning.
Paraquat (1,1-dimethyl-4,4-bipyridyl) is a contact 
herbicide that is used worldwide [1]. The production 
Table 3 — Survival profiles of patients with paraquat 
intoxication
Characteristic
 Dead Alive 
p
 (n = 28) (n = 4)
Group*   1.000
 MP  14 2 
 Control 14 2 
Sex*   0.033‡
 Male 13 0 
 Female 13 4 
SIPP (hr ˜ mg/L)*   < 0.001‡
 ≤ 10 1 4 
 > 10 27 0 
Age (yr)† 45.79 ± 14.56 30.25 ± 6.24 0.030‡
Plasma paraquat  37.29 ± 74.77 0.25 ± 0.19 0.002‡
 level (mg/L)†
BUN (mg/dL)† 23.50 ± 28.35 10.00 ± 4.24 0.188
Creatinine (mg/dL)† 3.51 ± 2.88 0.88 ± 0.15 0.009‡
AST (U/L)† 98.11 ± 194.96 141.50 ± 211.74 0.732
ALT (U/L)† 36.79 ± 37.01 95.00 ± 81.03 0.110
Time to arrival (hr)† 7.04 ± 4.57 3.00 ± 1.41 0.035‡
*Data are presented as n and analyzed using χ2 test; †data are pre-
sented as mean ± standard deviation and analyzed using nonpara-
metric Mann-Whitney U test; ‡p < 0.05. MP = methylprednisolone; 
SIPP = severity index of paraquat poisoning; BUN = blood urea nitrogen; 
AST = aspartate aminotransferase; ALT = alanine aminotransferase.
Table 2 — Comparison of parameters between the 
methylprednisolone (MP) and control groups*
 MP group Control group 
p† (n = 16) (n = 16)
Age (yr) 43.5 ± 4.2 44.2 ± 15.6 0.706
Plasma paraquat  47.8 ± 97.3 17.5 ± 20.5 0.880
 level (mg/L)
BUN (mg/dL) 29.9 ± 35.9 13.8 ± 8.1 0.104
Creatinine (mg/dL) 3.5 ± 2.9 2.8 ± 2.8 0.174
AST (U/L) 163.6 ± 263.3 43.5 ± 28.4 0.083
ALT (U/L) 54.9 ± 60.3 33.3 ± 26.2 0.365
Survival time (hr) 40.4 ± 25.1 63.5 ± 95.9 0.927
Time to arrival (hr) 6.4 ± 4.4 6.7 ± 4.8 0.492
SIPP (hr ˜  mg/L) 320.8 ± 815.6 107.9 ± 148.0 0.734
*Data are presented as mean ± standard deviation; †nonparametric 
Mann-Whitney U test. BUN = blood urea nitrogen; AST = aspartate 
aminotransferase; ALT = alanine aminotransferase; SIPP = severity 
index of paraquat poisoning.
Table 1 — Characteristics of paraquat intoxication in 
the methylprednisolone (MP) and control groups*
 MP group Control group 
p† (n = 16) (n = 16)
Sex   0.069
 Male 12 (75) 7 (43.8)
 Female 4 (25) 9 (56.3)
Survival   1.000
 No 14 (87.5) 14 (87.5) 
 Yes 2 (12.5) 2 (12.5) 
SIPP (hr ˜  mg/L)   0.625
 ≤ 10 2 (12.5) 3 (18.8) 
 > 10 14 (87.5) 13 (81.2) 
*Data are presented as n (%); †χ2 test. SIPP = severity index of 
paraquat poisoning.
Table 4 — Multivariate stepwise linear regression anal-
ysis of sex, severity index of paraquat poisoning (SIPP), 
age, plasma paraquat level, time to arrival and creati-
nine: correlation to survival in patients with paraquat 
intoxication
 β R2 p
SIPP > 10 (hr ˜  mg/L) −0.823 0.771 < 0.001*
*p < 0.05 is considered statistically significant in multivariate step-
wise linear regression analysis.
 TZU CHI MED J  June 2009  Vol 21  No 2 159
of free radicals by single electron reduction during 
photosynthesis is responsible for the herbicidal action 
of paraquat [11]. Oxygen free radicals are responsible 
for toxicity in humans by producing injury to intracel-
lular membranes and organelles and eventually cell 
death [4]. The lung is the primary target organ because 
of the active, energy-dependent uptake of paraquat by 
alveolar epithelium via the poly amine uptake pathway 
[11,12]. Initially, there is alveolitis which then prog-
resses to fibrosis and results in death from hypoxemia 
[11,12]. The estimated lethal dose in adults is about 
3–6 g of paraquat ions [12]. Lin et al reported that 
severe inflammation plays a critical role in producing 
lethal hypoxemia in patients with paraquat poisoning 
and combined repeated methylprednisolone pulse 
therapy preceding continuous dexamethasone treat-
ment can attenuate the severe inflammation from 
severe paraquat poisoning [9]. They also used 1 g cy-
clophosphamide per day for 2 days and 1 g methyl-
prednisolone per day for 3 days to treat patients with 
moderate-to-severe paraquat poisoning (survival > 7 
days after paraquat poisoning patients), and their re-
sults demonstrated that pulse therapy with cyclophos-
phamide and methylpredniso lone may be effective 
in treating patients with moderate to severe paraquat 
poisoning, but it was not effective in treating patients 
with fulminant paraquat poisoning [13]. In our study, 
there were no significant differences in the biochem-
ical data and survival between the MP group and 
control group. The reason may be that in our study, 
most of the patients had fulminant paraquat poison-
ing and not moderate to severe paraquat poisoning. 
Further studies are needed to assess the benefits of 
methylprednisolone pulse therapy in patients with 
moderate-to-severe paraquat poisoning.
Proudfoot et al showed that survival was deter-
mined by two primary variables: time elapsed since in-
gestion and plasma paraquat levels [14]. Lee et al [15] 
and Hong et al [16] reported that initial parameters 
other than plasma paraquat concentration, including 
blood pH, PaCO2, age, respiratory rate, hemoglobin, 
white blood cell count, BUN, amylase, and the number 
of failed organs, were associated with survival after 
paraquat poisoning. Sawada et al reported that such 
survival curves were of limited use in the quantita-
tive evaluation of the severity of poisoning and de-
veloped SIPP [17]. Yamamoto et al reported that 
SIPP = 10 (hour ˜  mg/L) indicated the boundary for 
survival and death [10]. In our study, time elapsed 
since ingestion of paraquat, serum BUN, AST and ALT 
were not associated with death. SIPP level less than 
10, young age, female sex, low initial plasma paraquat 
level, lower elapsed time from ingestion of the paraquat 
to arrival at hospital, and low serum Cr level were as-
sociated with survival in patients with paraquat poi-
soning. In our study, female patients with paraquat 
poisoning had lower initial plasma paraquat levels 
than male patients with paraquat poisoning (female, 
17.03 ± 17.52 mg/L; male, 39.49 ± 90.04 mg/L). How-
ever, there were no significant differences in the ini-
tial plasma paraquat levels between the female and 
male patients (p = 0.384). Moreover, multivariate for-
ward stepwise linear regression analysis of the mor-
tality rate showed that SIPP > 10 was an independent 
predictor of death in patients with paraquat poisoning 
and explained 77.1% of the variance.
Our study has some limitations. First, the number 
of patients enrolled was small and more patients are 
needed for further analysis. Second, this study did not 
check the serum paraquat levels during or after treat-
ment in the MP group and the control group. Further 
studies are needed to show the association of prog-
nosis with serum paraquat levels at different days after 
treatment in the MP group and the control group.
In conclusion, treatment with methylprednisolone 
pulse therapy did not improve survival in patients 
with oral paraquat poisoning. SIPP was an indepen-
dent predictor of death in patients with oral paraquat 
poisoning.
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